Dr. Debabrata Roy

DR. DEBABRATA ROY

MD, DM (CARDIOLOGY), FACC, FESC, FSCAI, FJCS, MAHA

Dr. Debabrata Roy is currently Member of Governing Body of World Heart Federation, Executive Committee Member, Cardiological Society of India (CSI) and International & Inter-Institutional Relations Coordinator of CSI and Senior Consultant Interventional Cardiologist & Academic Co-ordinator, NH-RTIICS, Kolkata.

His areas of interest are Preventive Cardiology, Lipidology, Hypertension, Interventional Cardiology.

He got WHF Award for Outstanding Contribution to Global CV Health in 2026.

CSI Projects headed by him, got World Heart Grant 2021 from WHF, ACC Chapter/Section Grant 2024 from ACC and Outstanding Chapter Innovation Award during ACC 2025 at Chicago.

Dissertations guided by him got Travel Award in ACC Middle East 2022 and ACC Asia 2024, Young Investigator’s Award in ESC Asia 2022 and Certificate of Commendation from NBEMS in 2023.

He is heading the “School Children Health Project” and “Pan India Survey of Prescription Patterns, Treatment Adherence, and Control of Traditional Cardiovascular Risk Factors – Hypertension, Diabetes, Dyslipidaemia, and Tobacco Use”, initiated from CSI. He is also involved with Indian Institute of Technology Delhi on a project titled “Assessing the Combined Impact of Heat and Air Pollution on Cardiovascular Health Across India: A Time-Series Analysis.” In addition, he is collaborating with Indian Statistical Institute on the project “Development of AI Analytical Models to Detect Potential Aberrations in Phono-Cardiogram Signals.

Dr. Roy is also involved with Tata Consultancy Services Ltd. on projects namely “Retrospective and Continuous Analysis of Unobtrusive Sensor Data for Early Prediction of Cardiovascular Disease” and “Developing Cardiac Risk Score model for Indian population”.

He published/presented around 120 papers in different national/international journals and conferences and served as Member of the Writing Group of Cardiological Society of India’s several Position Statements on STEMI, COVID-19 and Heart Failure, Acute MI care during COVID-19, CSI Clinical Practice Guidelines for Dyslipidemia Management etc.